title: Infliximab for severe gastrointestinal bleeding in Crohn's disease.
authors.forename: Yugo
authors.initials: Y
authors.lastname: Ando
authors.forename: Mitsunobu
authors.initials: M
authors.lastname: Matsushita
authors.forename: Seiji
authors.initials: S
authors.lastname: Kawamata
authors.forename: Masaaki
authors.initials: M
authors.lastname: Shimatani
authors.forename: Toshihito
authors.initials: T
authors.lastname: Fujii
authors.forename: Kazuichi
authors.initials: K
authors.lastname: Okazaki
mesh_terms: D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D003113:Colonoscopy; D003424:Crohn Disease / Q000150:complications* / Q000175:diagnosis; D005260:Female; D005500:Follow-Up Studies; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006471:Gastrointestinal Hemorrhage / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D000069285:Infliximab; D007262:Infusions, Intravenous; D012720:Severity of Illness Index
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab